Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
304.00    0.00 (0.00%)
Bid:
304.00
Ask:
304.50
Spread: 0.50 (0.164%)
Market Cap: £179.47m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Transaction in Own Shares

28 May 2025 07:00

RNS Number : 2952K
Treatt PLC
28 May 2025
 

28 May 2025

TREATT PLC

("Treatt" or the "Company")

Transaction in Own Shares

TREATT PLC ("Treatt" or the "Company") announces today it has purchased the following number of its ordinary shares of 2p each ("Ordinary Shares") through Peel Hunt LLP as part of its share buyback programme, details of which were announced by Treatt on 10 April 2025.

 Date of purchase

 27 May 2025

 Number of common shares purchased:

 138,488

 Lowest price paid per share (pence):

 275.50

 Highest price paid per share (pence):

 278.25

 Weighted average price per day (pence):

 277.08

The Company intends to hold the purchased Ordinary Shares in treasury. Following the purchase and settlement of these Ordinary Shares, the Company will hold 1,637,260 of its Ordinary Shares in treasury and will have 59,641,802 Ordinary Shares in issue (excluding treasury shares). The total number of shares held in the Employee Benefit Trust and Treatt SIP Trust, under which voting rights are waived, is 391,711. Therefore, the total number of voting rights in the Company is 59,250,091 and this figure may be used by shareholders in their calculations when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The table below contains detailed information about the purchases made as part of the buyback programme.

Aggregate information:

 Venue

 Volume Weighted Average Price (p)

 Aggregated Volume

 Lowest price per share (p)

 Highest price per share (p)

XLON

 277.08

 138,488

 275.50

 278.25

Individual transactions:

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company is detailed below:

 Number of shares purchased

 Price (pence per share)

 Trading Venue

 Time of transaction

 Transaction Reference

10,000

278.25

XLON

09:00:08

00177419659TRLO0

25,000

277.00

XLON

09:55:21

00177426102TRLO0

55,000

277.00

XLON

11:50:00

00177436139TRLO0

20,000

275.50

XLON

14:32:32

00177449476TRLO0

28,488

278.00

XLON

16:15:48

00177469170TRLO0

  For further enquiries: Treatt PLC Nick Hartigan General Counsel and Company Secretary 01284 702500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQDLFLEELFBBK
Date   Source Headline
25th Jul 201912:07 pmRNSSecond Price Monitoring Extn
25th Jul 201912:02 pmRNSPrice Monitoring Extension
24th Jul 20193:26 pmRNSDirector/PDMR Shareholding
22nd Jul 20194:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20194:35 pmRNSPrice Monitoring Extension
18th Jul 201912:07 pmRNSSecond Price Monitoring Extn
18th Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jul 201912:07 pmRNSSecond Price Monitoring Extn
10th Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 201912:02 pmRNSPrice Monitoring Extension
3rd Jul 20194:07 pmRNSHolding(s) in Company
2nd Jul 20193:37 pmRNSTotal Voting Rights
2nd Jul 201912:07 pmRNSSecond Price Monitoring Extn
2nd Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jun 20194:40 pmRNSSecond Price Monitoring Extn
10th Jun 20194:35 pmRNSPrice Monitoring Extension
4th Jun 20194:26 pmRNSBlock Listing Six Monthly Return
15th May 20191:02 pmRNSDirector Declaration
14th May 20197:00 amRNSBoard Committee Changes
7th May 20197:00 amRNSHalf-year Report
5th Apr 20197:00 amRNSTrading Update
25th Mar 20195:51 pmRNSDirector/PDMR Shareholding
25th Mar 20195:51 pmRNSDirector/PDMR Shareholding
15th Mar 20194:10 pmRNSDirector/PDMR Shareholding
6th Mar 20199:27 amRNSDirector/PDMR Shareholding
6th Feb 20191:10 pmRNSBoard Appointments
25th Jan 20194:14 pmRNSResult of AGM
17th Jan 20195:05 pmRNSDirector/PDMR Shareholding
11th Jan 20195:09 pmRNSDirector/PDMR Shareholding
7th Jan 20192:45 pmRNSDirector/PDMR Shareholding
31st Dec 20187:30 amRNSTotal Voting Rights
19th Dec 20184:51 pmRNSDirector/PDMR Shareholding
18th Dec 20183:53 pmRNSDirector/PDMR Shareholding
17th Dec 20189:16 amRNSHolding(s) in Company
10th Dec 20189:16 amRNSHolding(s) in Company
7th Dec 201811:22 amRNSAnnual Report
4th Dec 20183:58 pmRNSHolding(s) in Company
3rd Dec 201812:06 pmRNSBlock Listing Six Monthly Return
27th Nov 20187:00 amRNSFinal Results
16th Nov 201812:07 pmRNSSecond Price Monitoring Extn
16th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 201812:13 pmRNSHolding(s) in Company
13th Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
6th Nov 20183:44 pmRNSHolding(s) in Company
16th Oct 20189:30 amRNSBoard Change
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.